Marché mondial des tests et traitements des maladies entériques – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et perspectives du marché mondial des tests et traitements des maladies entériques

Data Bridge Market Research analyse que le marché des tests et traitements des maladies entériques devrait croître à un TCAC de 4,30 % au cours de la période de prévision 2022-2029. Le marché devrait connaître une expansion rapide en termes de capitalisation, car les principaux acteurs du marché se concentrent sur le développement de produits qui aident les médecins et les patients à mieux prodiguer les soins de santé.

Les maladies entériques sont un type de maladie intestinale causée par la présence de divers micro-organismes tels que des parasites, des virus et des bactéries. Ces micro-organismes sont couramment présents dans divers produits alimentaires et plans d'eau, et cette catégorie de maladies est également transmissible entre individus. Les tests et le traitement des maladies entériques font référence aux différentes solutions diagnostiques et thérapeutiques proposées par les acteurs du marché pour réduire ou éliminer l'impact des maladies entériques sur le corps humain.

Au cours de la période de prévision, le nombre croissant de patients souffrant de maladies ciblées constituera un moteur important de la croissance du marché des tests et traitements des maladies entériques. La disponibilité de produits de meilleure qualité basés sur des technologies avancées plutôt que sur des méthodes traditionnelles stimule également la croissance du marché. En outre, l'intervention accrue du gouvernement pour améliorer le niveau de vie de la population devrait avoir un impact positif sur le marché. Le gouvernement est le principal responsable de l'évolution de la tendance des méthodes de diagnostic traditionnelles vers des méthodes avancées.

Le marché des tests de maladies entériques est freiné par les coûts élevés des équipements et de la main-d'œuvre, ainsi que par la nécessité de conditions de laboratoire sophistiquées pour les diagnostics cliniques. Ces difficultés devraient être surmontées à l'avenir grâce au développement de diverses technologies avancées à faible coût telles que le test immuno-enzymatique (ELISA) et la réaction en chaîne par polymérase (PCR).

This enteric disease testing-treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on enteric disease testing-treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Enteric Disease Testing-Treatment Market Scope and Market Size

Enteric disease testing - treatment market is segmented on the basis of disease type, therapeutics, testing technology and end user. Each individual segment’s growth is analysed and these insights are subsequently considered before providing you with the market overview which can help you in understanding and identification of your core applications in the broad market.

• On the basis of disease type, the enteric disease testing - treatment market has been segmented into bacterial enteric diseases, viral enteric diseases and parasitic enteric diseases. Bacterial enteric diseases have been further segmented into C.difficile infection, campylobacteriosis, cholera, E.coli infection, H.pylori infection, salmonellosis and shigellosis. Viral enteric diseases have been sub-segmented into rotavirus infection and norovirus infection. Parasitic enteric diseases have segmented into amebiasis, cryptosporidiosis and giardiasis.
• Based on therapeutics, the enteric disease testing - treatment market has been segmented into campylobacter, cryptosporidium, E-Coli, enteroviruses, RhinoViruses, RotaVirus (REOVIRUS), salmonellosis and shigellosis.
• Enteric disease testing-treatment market has been segmented on the basis of testing technology into molecular diagnostics, monoclonal antibodies, immunoassays, differential light scanning, information technology, artificial intelligence (AI), liposomes, flow cytometry, chromatography, diagnostic imaging, gel microdroplets, others
• Based on end user, the enteric disease testing-treatment market has been segmented into hospitals, diagnostic laboratories and physician offices.

Enteric Disease Testing-Treatment Market Country Level Analysis

The enteric disease testing-treatment market is analysed and market size insights and trends are provided by country, disease type, therapeutics, testing technology and end user as referenced above.

The countries covered in the enteric disease testing-treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific will be the most dominant region for the enteric disease testing-treatment market, with the majority of the population living in urban areas suffering from some form of enteric disease. This population is also migrating to cities, increasing demand for higher-quality healthcare services such as diagnostic products, treatment, and other solutions.

The country section of the enteric disease testing-treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The enteric disease testing-treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for enteric disease testing-treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the enteric disease testing-treatment market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Enteric Disease Testing-Treatment Market Share Analysis

The enteric disease testing-treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to enteric disease testing-treatment market.

Français Certains des principaux acteurs opérant sur le marché des tests et traitements des maladies entériques sont Abbott, BD, Biomerica, Inc., bioMérieux SA, Bio-Rad Laboratories, Inc., Cepheid, CorisBioconcept SPRL, DIASORIN SpA, Meridian Bioscience, Inc., Quest Diagnostics Incorporated, Trinity Biotech Ireland, Thermo Fisher Scientific Inc., Mobidiag Ltd., R-Biopharm, GlaxoSmithKline plc, Bharat Biotech, Sanofi, Janssen Global Services, LLC, Eli Lilly and Company, IDL Biotech AB (publ), Merck & Co., Inc., Novartis AG et Takeda Pharmaceutical Company Limited, entre autres.

SKU-24757